Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: A comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs E Gibbs, ME Karim, J Oger January 2015 Source Document multiple-sclerosis Related Beta-interferon exposure and onset of secondary progressive multiple sclerosis Multiple sclerosis in older adults: the clinical profile and impact of interferon beta treatment Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study Marginal structural Cox models for estimating the association between beta-interferon exposure and disease progression in a multiple sclerosis cohort Interferon beta and long-term disability in multiple sclerosis